Re the pps this could be known as hell week in pen
Post# of 9122
many long investors return in Jan -Feb and I've posted what I think needs to be done re otc classification to capture their attention
the following board member is no doubt of great use in acquiring NNLX's numerous patents
Gwen R. Acker Wood, Ph.D. J.D
Dr. Gwen R. Acker Wood is a registered patent attorney with expertise in the areas of biotechnology, pharmaceuticals, biomechanical devices, medicinal chemistry and life sciences. Dr. Wood’s practice focuses on preparation and prosecution of U.S. and foreign patent applications, patent searching, patentability and infringement/freedom-to-operate opinions, due diligence analyses and U.S. and foreign patent portfolio strategy and management. Dr. Wood has been a practicing attorney for more than nine years, and worked for large law firms in Pennsylvania and Ohio before opening Acker Wood IP Law.
Dr. Wood has an M.S. in hematology and a Ph.D. in neurophysiology. Prior to becoming a patent attorney, Dr. Wood was a research scientist, receiving two postdoctoral scholarships to conduct research in the areas of neurochemistry and psychoimmunology, respectively. In addition, she served as an adjunct professor at the following institutions in the following disciplines: biology, nutritional science and advanced pathophysiology at New York University, and biology and advanced pathophysiology at Duquesne University.
Dr. Wood is admitted to practice in the Commonwealth of Pennsylvania, the State of Ohio, the United States Patent and Trademark Office, and the Western District of Pennsylvania.